首页/数据集/RNAseq analysis of cell lines established from patient-derived luminal breast cancer xenografts

RNAseq analysis of cell lines established from patient-derived luminal breast cancer xenografts

NIAID Data Ecosystem2026-03-14 收录

乳腺癌PDX模型

管腔型乳腺癌转录组

数据链接：

https://www.ncbi.nlm.nih.gov/sra/SRP250931 数据链接链接失效反馈

官方服务：

资源简介：

Breast cancer cell lines from PDX models Overall design: Six breast cancer cell lines grown in regular media

应用场景：

创建时间：

2023-01-11

相关数据集

BROCADE

乳腺癌PDX模型

肿瘤转化机制

Repository of primary and metastatic breast cancer tissue and matching mouse PDX models and clinical data.

DataCite Commons2020-09-22 更新70

Additional file 3 of Factors associated with engraftment success of patient-derived xenografts of breast cancer

乳腺癌PDX模型

临床病理决策树分析

Additional file 3: Table 1. Decision tree analysis with AI and clinicopathological factors in primary breast cancer group, including the chemo-naïve and NAC groups (n = 320). Table 2. Decision tree an

Figshare2024-08-18 更新40

Transcriptome analysis of paired luminal breast tumor and para-carcinoma tissues. Transcriptome analysis of paired luminal breast tumor and para-carcinoma tissues

管腔型乳腺癌转录组

差异表达基因分析

With stringent filtering criteria (fold change>2, p<0.001 and False Discovery Rate (FDR) <0.01), we identified 133 lncRNAs and 370 mRNAs that were the most highly differentially expressed. Of all the

NIAID Data Ecosystem30

BROCADE

乳腺癌PDX模型

肿瘤转化医学研究

Repository of primary and metastatic breast cancer tissue and matching mouse PDX models and clinical data.

NIAID Data Ecosystem40

Xenografting of advanced stage breast cancer preserves the genomic and clonal architecture and captures luminal tumors harboring mutations and gene rearrangements in ESR1. Homo sapiens

乳腺癌PDX模型

内分泌治疗耐药机制

End-stage breast cancers are clonally heterogeneous and harbor many poorly-understood treatment resistance mechanisms. We therefore established multiple Patient-Derived-Xenograft (PDX) models to study

NIAID Data Ecosystem30